Metabolic Syndrome as a Risk for Coronary Heart Disease in Indonesia: A Longitudinal Study 2007-2014
https://doi.org/10.47836/mjmhs.18.5.13
- Author:
Fariha Ramadhaniah
1
;
Mondastri Korib Sudaryo
1
;
Syahrizal Syarif
1
Author Information
1. Department of Epidemiology, Faculty of Public Health, Universitas Indonesia, Depok, Indonesia, 16424
- Publication Type:Journal Article
- Keywords:
CHD, metabolic syndrome, cohort, IFLS, Indonesia
- From:Malaysian Journal of Medicine and Health Sciences
2022;18(No.5):86-92
- CountryMalaysia
- Language:English
-
Abstract:
Introduction: Indonesia has a serious burden of cardiovascular disease, especially coronary heart disease (CHD).
The prevalence of CHD has not in fact increased; however, there has been a significant increase in the prevalence of
CHD risk factors. Several of these occurring together could cause metabolic syndrome, whose prevalence is relatively high in Indonesia, and consequently increase the risk of CHD. This study aims to obtain the risk of CHD in patients
with metabolic syndrome in Indonesia. Methods: This is a retrospective cohort study with a median followed up of
6.8 years, secondary data from the Indonesian Family Life Survey (IFLS) waves 4 and 5 (2007-2014), and a study
population of 6,571 respondents aged 40-69 years. The Joint Interim Statement criteria were used to define metabolic syndrome, with the omission of one component. Results: The prevalence of metabolic syndrome was 20%; the
highest component was low HDL at 69.1%, followed by hypertension at 59.7%, and central obesity at 39.7%. The
incidence of CHD was 2.72%, with an incidence rate 34per 100,000 person-years. Multivariate analysis found that
the relative risk (RR) hazard ratio (HR) was 2.16 (95% CI 1.564-2.985). Conclusion: Subjects with metabolic syndrome had a two times higher risk of developing CHD, as adjusted by sex, age, smoking status, and physical activity.
- Full text:11.2022my1332.pdf
